Flavin monooxygenase 3 (FMO3) polymorphism in a white population: allele frequencies, mutation linkage, and functional effects on clozapine and caffeine metabolism
about
Genetic polymorphisms of human flavin-containing monooxygenase 3: implications for drug metabolism and clinical perspectivesGenomewide association for schizophrenia in the CATIE study: results of stage 1How to manage individualized drug therapy: application of pharmacogenetic knowledge of drug metabolism and transport.Can valproic acid be an inducer of clozapine metabolism?Human flavin-containing monooxygenase (form 3): polymorphisms and variations in chemical metabolism.Benzydamine N-oxidation as an index reaction reflecting FMO activity in human liver microsomes and impact of FMO3 polymorphisms on enzyme activity.Flavin-containing monooxygenase genetic polymorphism: impact on chemical metabolism and drug development.Flavin-containing monooxygenase 3 and human disease.The potential of knockout mouse lines in defining the role of flavin-containing monooxygenases in drug metabolism.Drug metabolism by flavin-containing monooxygenases of human and mouse.Flavin-containing monooxygenase 3 polymorphisms in 13 ethnic populations from Europe, East Asia and sub-Saharan Africa: frequency and linkage analysis.Association of Flavin Monooxygenase Gene E158K Polymorphism with Chronic Heart Disease Risk.Genetic polymorphisms of flavin monooxygenase 3 in sulindac-induced regression of colorectal adenomas in familial adenomatous polyposis.Effects of FMO3 Polymorphisms on Pharmacokinetics of Sulindac in Chinese Healthy Male Volunteers.Flavin-containing monooxygenase 3 gene polymorphisms in Turkish population.Development of a physiologically based pharmacokinetic model to predict the effects of flavin-containing monooxygenase 3 (FMO3) polymorphisms on itopride exposure.Antioxidant-related gene polymorphisms associated with the cardio-ankle vascular index in young Russians.
P2860
Q28305656-A5434CB6-155F-40E8-86E3-6D49564AB529Q28659652-17770D51-FB02-4621-BFE5-DEF4C9A9A52FQ34093093-674B5DD6-3399-4DCD-8621-CE4E3CF831B3Q34497477-1289E92A-7EE8-4087-ADD6-CDE150AEFB51Q34673357-AD142E52-8F11-4400-875D-0195CDB4659EQ36055351-3358D858-9841-44C3-B94C-4E35C8F7E3DAQ36316996-7B827BC7-47D7-4403-9B30-3EE63B76A149Q37008890-6A15770E-50B8-4336-8BDD-E0324FF2DE61Q37772507-057B0F95-C721-44DA-A495-194EF3018C8DQ38966423-A1B6A3A3-5BFF-4C72-A2E3-706AD0EE37B3Q39213310-A2CA06D4-884E-4169-8CD4-14C29B9CEDDFQ41165713-40BEDE86-E776-4669-9B20-4FD22B297C8EQ41995896-66D2DDE9-A19A-4737-8073-CA23C316AD38Q42317058-44831299-9FB2-4B9D-8500-7E2546BFB4D1Q48031007-9D39B445-7D63-423F-ADCE-874FE7C25F09Q48168817-B994480A-4C3E-4375-BA5A-BD9433C0AD61Q51350352-86F42FD2-3EEE-4720-AE75-E1E4DE28A2B7
P2860
Flavin monooxygenase 3 (FMO3) polymorphism in a white population: allele frequencies, mutation linkage, and functional effects on clozapine and caffeine metabolism
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Flavin monooxygenase 3 (FMO3) ...... zapine and caffeine metabolism
@ast
Flavin monooxygenase 3 (FMO3) ...... zapine and caffeine metabolism
@en
Flavin monooxygenase 3 (FMO3) ...... zapine and caffeine metabolism
@nl
type
label
Flavin monooxygenase 3 (FMO3) ...... zapine and caffeine metabolism
@ast
Flavin monooxygenase 3 (FMO3) ...... zapine and caffeine metabolism
@en
Flavin monooxygenase 3 (FMO3) ...... zapine and caffeine metabolism
@nl
prefLabel
Flavin monooxygenase 3 (FMO3) ...... zapine and caffeine metabolism
@ast
Flavin monooxygenase 3 (FMO3) ...... zapine and caffeine metabolism
@en
Flavin monooxygenase 3 (FMO3) ...... zapine and caffeine metabolism
@nl
P2093
P1476
Flavin monooxygenase 3 (FMO3) ...... zapine and caffeine metabolism
@en
P2093
B Müller-Oerlinghausen
J Brockmöller
M Dettling
P356
10.1053/CP.1999.V66.A102203
P407
P577
1999-10-01T00:00:00Z